pS2 and response to adjuvant hormone therapy in primary breast cancer.
about
Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cellsTFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivationTrefoil factor 1 in early breast carcinoma: a potential indicator of clinical outcome during the first 3 years of follow-upTime at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein.mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers.Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance.
P2860
Q24314806-588D3DB1-B4A7-4C94-A143-8E0EB3A2766CQ27853155-97DBA53F-FA21-4CA2-8633-EE704F320FA4Q28288879-A83F173F-C146-46C7-8903-2FADDC9060C9Q33628415-CC3EA66F-892C-4C04-88EA-60FFEA3D93C1Q36618820-0E7A9B91-03C2-4247-A60F-D7B56DDB24C7Q38336598-BF991AF5-8A5A-4DD3-8BF2-B83B79472A24Q45152343-78D1BC96-A581-4443-ADCD-D1B4EFBE81BAQ46788875-45F1130A-AE1A-43FE-8F5F-CA73E3AF5800
P2860
pS2 and response to adjuvant hormone therapy in primary breast cancer.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@ast
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@en
type
label
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@ast
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@en
prefLabel
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@ast
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@en
P2093
P2860
P356
P1476
pS2 and response to adjuvant hormone therapy in primary breast cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.73
P407
P577
1994-02-01T00:00:00Z